By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Coffee & Health
Part of
Cardiovascular health
More information
Affects of coffee consumption
  1. Mostofsky E, et al. (2012). Habitual coffee consumption and risk of heart failure: a     dose-response meta-analysis. Circ Heart Fail. 5(4):401-5.
  2. Malerba S, et al. (2013): A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol, 28(7):527-39.
  3. Liu J, et al. (2013). Association of Coffee Consumption with All-Cause and     Cardiovascular Disease Mortality. Mayo Clinic Proc. 88:10.
  4. Rebello SA & van Dam RM. (2013). Coffee Consumption and Cardiovascular     Health: Getting to the Heart of the Matter. Curr CardiolReps. 15:403.
  5. Ding M, et al (2014). Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circ. 129(6):643-59.
  6. Crippa A, et al. (2014). Coffee consumption and mortality from all causes,     cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol, 180(8):763-75.
  7. Rodriguez Artalejo F & Lopez Garcia E. (2017). Coffee Consumption and Cardiovascular     Disease: A condensed review of epidemiological evidence and mechanisms, J Agric Fd Chem. 66(21):5257-63.
  8. O’Keefe JH, et al. (2018): Coffee for Cardioprotection and Longevity. Prog Cardiovasc Dis. 61(1):38-42.
  9. Voskoboinik A, et al. (2018): Cardiovascular effects of caffeinated beverages. Trends in Cardiovasc Med. S1050-1738(18)30177-4.
  10. Wu J, et al. (2009): Coffee consumption and the risk of coronary heart disease: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 137:216-25.
  11. Sugiyama K, et al. (2010). Coffee consumption and mortality due to all causes,     cardiovascular disease, and cancer in Japanese women. J Nur. 140(5):1007-13.
  12. de Koning Gans JM, et al. (2010). Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 30:1665-71.
  13. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). (2015). Scientific Opinion on the safety of caffeine. EFSA Journal. 13(5):4102.
  14. Ahmed HN, et al. (2009). Coffee consumption and risk of heart failure in men: an analysis from the cohort of Swedish men. Am Heart J. 158:667-72.
  15. Nilson LM, et al. (2009). Consumption of filtered and boiled coffee and the risk of first acute myocardial infarction: a nested case/referent study. Nutr Metabol & Cardiovasc Dis. 20(7):527-35.
  16. Larrson SC & Orsini N. (2011). Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies. Am J Epidemiol. 174(9):993-1001.
  17. Kim B, et al. (2012). Coffee consumption and stroke risk: A meta-analysis of     epidemiologic studies. Korean J Fam Med. 33(6):356-65.
  18. Lopez-Garcia E.,et al. (2009). Coffee consumption and risk of stroke in women. Circ.     119:1116-23.
  19. Leurs LJ, et al. (2010): Total fluid and specific beverage intake and mortality due to ID and stroke in the Netherlands cohort study. Br J Nutr. 104:1212-21.
  20. Lutsey PL, et al. (2009): Dietary intake and the development of the metabolic     syndrome. The Atherosclerosis Risk in Communities Study. Am Heart J1. 57:1081
  21. Liebeskind DS, et al. (2015): The coffee paradox in stroke: increased consumption     linked to fewer strokes. Nutr Neurosci. 22:1476–8305.
  22. Kokubo Y, et al. (2013). The Impact of Green Tea and Coffee Consumption on the     Reduced Risk of Stroke Incidence in Japanese Population: The Japan Public Health Center-Based Study Cohort. Stroke. 44(5):1369-74.
  23. Deng C. (2018). Strokeand food groups: an overview of systematic reviews and meta-analyses. Pub Health Nutr. 21(4):766-76.
  24. Lee J, et al (2017). Relationship betweencoffee consumption and stroke risk in Korean population: the Health Examinees (HEXA) Study. Nutr J. 16(1):7.
  25. Cheng M, et al. (2014). Caffeine Intake and Atrial Fibrillation Incidence: Dose Response Meta-analysis of Prospective Cohort Studies. Can J Cardiol. 30(4):448-54.
  26. Caldeira D, et al. (2013): Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart. 99:1383-9.
  27. Mostofsky E, et al. (2015). Risk of Atrial Fibrilation Associated with Coffee Intake: Findings from the Danish Diet, Cancer, and Health Study. Eur J Prev Cardiol. 23(9):922-30.
  28. Larsson SC, et al. (2015). Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis. BMC Medicine. 13(1):207.
  29. Conen D, et al. (2010). Caffeine consumption and incident atrial fibrillation in     women. AJCN. 92(3):509-14.
  30. Frost L & Vestergaard P. (2005). Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer and Health Study. AJCN. 81:578-82.
  31. Casiglia E, et al. (2018). Caffeine intake reduces incident atrial fibrillation at a population level. Eur J Prev Cardiol. 25(10):1055-62.
  32. Abdelfattah R, et al. (2018). Does caffeine consumption increase the risk of new-onset     atrial fibrilation? Cardiology. 140(2):106-14.
  33. Geleijnse JM. (2008): Habitual coffee consumption and blood pressure: An     epidemiological perspective. Vasc Health Risk Man. 4(5):963-70.
  34. Mesas AE, et al. (2011). The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. AJCN. 94(4):1113-26.
  35. Zhang Z, et al. (2011). Habitual coffee consumption and risk of hypertension: a     systematic review and meta-analysis of prospective observational studies. AJCN. 93(6):1212-9.
  36. Rhee JJ, et al. (2016). Coffee and Caffeine Consumption and the Risk of Hypertension in Postmenopausal Women. AJCN. 103(1):210-7.
  37. Renda G, et al. (2012). Genetic determinants of blood pressure responses to caffeine drinking. AJCN. 95(1):241-8.
  38. Grosso G, et al. (2017). Long-Term Coffee Consumption Is Associated with Decreased Incidence of New-Onset Hypertension: A Dose-Response Meta-Analysis. Nutr. 9(8):890.
  39. Navarro AM, et al. (2017): Coffee consumption and risk of hypertension in the SUN     Project. Clin Nutr. S0261-5614(17)31429-2.
  40. D’Elia L, et al. (2017): Coffee consumption and risk of hypertension: a dose-response meta-analysis of prospective studies. Eur J Nutr. doi: 10.1007/s00394-017-1591-z.
  41. Xie C, et al. (2018): Coffee consumption and risk of hypertension: a systematic review and dose-response meta-analysis of cohort studies. J Hum Hypertens. 32(2):83-93.
  42. Miranda AM, et al. (2018): The association between genetic risk score and blood     pressure is modified by coffee consumption: Gene-diet interaction analysis in a population-based study. Clin Nutr. S0261-5614(18)31246-9.
  43. Urgert R & Katan MB. (1996).The cholesterol-raising factor from coffee beans. J R Med. 89(11):618-23.
  44. Jee SH, et al. (2001). Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 153:353-62.
  45. Nystad T, et al. (2010). The effect of coffee consumption on serum total cholesterol in the Sami & Norwegian populations. Public Health Nutrition. 13(11):1818-25.
  46. Correa TAF, et al. (2013). Paper filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree. Nutrition. 29:977-81.
  47. Grioni S, et al. (2015): Espresso coffee consumption and risk of coronary heart disease in a large Italian cohort. PLoS One. 6;10(5):e0126550.
  48. Buscemi S, et al. (2010): Acute effects of coffee on endothelial function in  healthy subjects. Eur J Clin Nutr. 64(5):483-9.
  49. Buscemi S, et al. (2010). Coffee and endothelial function: a battle between caffeine and antioxidants. Eur J Clin Nutr. 64:1242-3.
  50. Aqudelo-Ochoa GM. (2016). Coffee consumption increases the antioxidant capacity of     plasma and has no effect on the lipid profile or vascular function in healthy adults in a randomized controlled trial. J Nutr. 146(3):524-31.
  51. Refsum H, et al. (2006). The Hordaland Homocysteine Study: a community based study of homocysteine, its determinants, and associations with disease. J Nutr. 136 (6suppl):17731S-40S.
  52. Henkey GJ & Eikelboom JW. (1999). Homocysteine and Vascular Disease. Lancet.     354:407-13.
  53. Folsom AR, et al. (1998). Prospective study of coronary heart disease incidence     in relation to fasting homocysteine, related polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 98:204-10.
  54. Fallon UB, et al. (2001). Homocysteine and coronary heart disease in the Caerphilly cohort: a 10-year follow up. Heart, 85:53-158.
  55. Higdon JV & Frei B. (2006). Coffee and Health: A Review of Recent Human     Research. Crit Revs Fd Sci Nutr, 46:101-23.
  56. Grubben MJ, et al. (2000). Unfiltered coffee increases plasma homocysteine     concentrations in healthy volunteers: a randomized trial. AJCN. 71:448-84.
  57. Urgert RA, et al. (2000). Heavy coffee consumption and plasma homocysteine: a     randomized controlled trial in healthy volunteers. AJCN. 72:1107-10.
  58. Christensen B, et al. (2001). Abstention from filtered coffee reduces concentrations of plasma homocysteine and serum cholesterol – a randomized controlled trial. AJCN. 74(3):302-7.
  59. Espositio F, et al. (2003): Moderate coffee consumption increases plasma glutathione     but not homocysteine in healthy subjects. Aliment Pharmacol Therapy. 17:595-601.
  60. Verhoef P, et al. (2002). Contribution of caffeine to the homocysteine-raising  effect of coffee: a randomized controlled trial in humans. AJCN. 76:1244-8.
  61. Olthof MR, et al. (2001). Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. AJCN. 7(737):532-8.
  62. Zhang W, et al. (2009). Coffee consumption and risk of cardiovascular disease and all-cause mortality among men with type 2 diabetes. Diabetes Care. 32:1043-5.
  63. Mukanal KJ, et al. (2009): Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J. 157:495-501.
  64. Palatini P, et al. (2009). CYP1A2 genotype modifies the association between coffee     intake and the risk of hypertension. J Hypertension. 27(8):1594-601.
  65. Lopez-Garcia E, et al. (2016). Habitual coffee consumption and 24-hour blood pressure     control in older adults with hypertension. Clin Nutr. 35(6):1457-63.
  66. Notara V, et al. (2015). The role of coffee consumption on the 10-year (2004-2014) Acute Coronary Syndrome (ACS) Incidence among cardiac patients: the GREECS observational study. Int J Fd Sci & Nutr. 66(6):722-8.
  67. Brown OI, et al. (2016). Coffee reduces the risk of death after acute myocardial infarction: a meta-analysis. Coron Artery Dis. 27(7):566-72.
  68. Chrysant SG. (2017). The impact of coffee consumption on blood pressure,     cardiovascular disease and diabetes mellitus. Exp Rev Cardiovasc Thera. 15(3):151-6.
  69. Kastorini CM, et al. (2009). Moderate coffee consumption lowers the likelihood of developing  left ventricular systolic dysfunction in post-acute coronary syndrome     normotensive patients. J Med Food, 12(1):29-36.
  70. Richardson T, et al. (2009). Randomized control trials investigating the influence of     coffee on heart rate variability in patients with ST-segment elevation myocardial infarction. Q J Med, 102(8):555-61.
  71. Namdar M, et al. (2009): Caffeine impairs myocardial blood flow response to physical exercise in patients with artery disease as well as in age-matched controls. PloS ONE. 4(5):e5665.
  72. Shechter M, et al. (2011). Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Am J Cardiol, 107(9):1255-61.
  73. Townsend N, et al. (2016). Cardiovascular disease in Europe: epidemiological update     2016.Eur Heart J. 0, 1-14.
  74. European  Heart Network, ‘European Cardiovascular Disease Statistics 2017’. Available at:
  75. van Dam R. (2008). Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ. 337:a1440.
  76. Mozaffarian D, et al. (2008): Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circ. 117(23):3031-8.
  77. Natella F, et al. (2002): Coffee drinking influences plasma antioxidant capacity in humans. Food Chem. 50:6211-6.
  78. Williamson G. (2017): The role of polyphenols in modern nutrition. Nutr Bull. 42(3):226-35.

Latest research

All research

Information campaigns

All information campaigns